Data protection Impressum

Financing

GeNeuro‘s mission is to leverage HERV biology to develop safe and effective treatments for the benefit of patients, by neutralizing causal factors encoded by HERVs that represent 8% of human DNA.

GeNeuro secures EUR 5 million to advance post-COVID and neurodegenerative disease treatments

5 February 2024

In 2023, Swiss start-ups faced a challenging investment climate, marked by a significant reduction in venture capital funding.

Swiss start-ups raised CHF 2.6 billion in 2023

30 January 2024

Top Stories Western Switzerland

Top Stories from Western Switzerland (January 2024)

30 January 2024

Timeline’s new funding round, led by BOLD (Business Opportunities for L’Oréal Development), includes strategic investments from industry giants L’Oréal and Nestlé.

Timeline secures CHF 56 million to propel its pioneering role in longevity and healthy aging

24 January 2024

Cellestia Biotech is pioneering innovative therapeutics based on novel modes of action to treat autoimmune diseases and multi-drug resistant cancers.

Cellestia Biotech receives CHF 2 million for its pioneering GvHD prevention therapy

23 January 2024

STALICLA has developed the first neurodevelopmental disorder-specific precision medicine platform with an initial application in autism spectrum disorder (ASD).

STALICLA secures USD 17.4 million to propel neuro precision medicine

22 January 2024

The new funding will propel Enerdrape further in its journey as a pioneer in the clean energy sector, particularly with its innovation in prefabricated geothermal panel technology.

Enerdrape raises CHF 1.3 million to accelerate the deployment of its geothermal panels

16 January 2024

In the heart of Western Switzerland, the canton of Bern positions itself as a vibrant hub for startups. This thriving ecosystem is not just a result of the scenic beauty or the region's rich historical legacy, but a testament to a systematic and supportive environment for innovation and entrepreneurship.

The startup ecosystem in the canton of Bern

LEM Surgical's advancements in spinal surgery robotics represent a significant leap forward in medical technology, potentially transforming the lives of SCI patients globally.

LEM Surgical secures CHF 8.7 million to advance spinal surgery with robotic solutions

8 January 2024

This funding and partnership with the ADDF place GliaPharm at the forefront of developing effective treatments for Alzheimer’s, offering new hope in the fight against this challenging neurodegenerative disease.

GliaPharm receives USD 4.2 million to propel Alzheimer’s treatment development

20 December 2023

1 … 12 13 14 15 16 17 18 19 20 … 33